NCT07719179 Eco-guided Neuromodulation of the Femoral Nerve on the Performance of Amateur Athletes.
| NCT ID | NCT07719179 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Universitat Internacional de Catalunya |
| Condition | Healthy Volunteers |
| Study Type | INTERVENTIONAL |
| Enrollment | 23 participants |
| Start Date | 2026-09-01 |
| Primary Completion | 2026-09-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 23 participants in total. It began in 2026-09-01 with a primary completion date of 2026-09-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This randomized crossover study aims to evaluate whether different percutaneous electrical nerve stimulation (PENS) protocols produce changes in neuromuscular performance in healthy adults. PENS involves the ultrasound-guided application of an electrical current through a needle to modulate motor neuron excitability. Each participant will undergo five intervention sessions: (1) a long-term potentiation (LTP)-based protocol with impulse trains, (2) a 10 Hz protocol with 10 s stimulation and 10 s rest repeated ten times, (3) a 5-55 protocol with 100 Hz stimulation for 5 s followed by 55 s rest repeated five times, (4) a high-intensity burst (HIB) protocol applied at a high current intensity close to 1000 mA and repeated three times, and (5) a placebo condition. All interventions will be applied bilaterally by an experienced physiotherapist under ultrasound guidance, with a two-week washout between sessions. The objective of this trial is to assess whether these stimulation patterns produce measurable changes in squat execution velocity, jump performance, and quadriceps strength. The findings may help identify the most effective stimulation strategy for enhancing neuromuscular performance.
Eligibility Criteria
Inclusion Criteria: * Athletes aged between 18 and 30 years. * Familiarized with performing barbell back squats using an Olympic bar. * Engaged in regular training at least three times per week during the last six months. * Able to perform squat and jump tests safely. * Provided written informed consent to participate in the study. Exclusion Criteria: * Sports injury within the last two months or current inability to perform physical activity. * Inability to understand or follow the instructions provided by the therapist. * Participation in another research study during the same period. * Belonephobia (fear of needles). * Ongoing medical or pharmacological treatment that could interfere with neuromuscular performance (e.g., anticonvulsants, antidepressants, or similar medications).
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07719179 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 30 Years, studying Healthy Volunteers. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07719179 currently recruiting?
Yes, NCT07719179 is actively recruiting participants. Contact the research team at jrodriguezs@uic.es for enrollment information.
Where is the NCT07719179 trial being conducted?
This trial is being conducted at Sant Cugat del Vallès, Spain.
Who is sponsoring the NCT07719179 clinical trial?
NCT07719179 is sponsored by Universitat Internacional de Catalunya. The trial plans to enroll 23 participants.